Evidence map›Paper›PMID 36173330›Full record

ArticleG3 (Bethesda, Md.)2022

yEvo: experimental evolution in high school classrooms selects for novel mutations that impact clotrimazole resistance in Saccharomyces cerevisiae.

Matthew Bryce Taylor, Ryan Skophammer, Alexa R Warwick, Renee C Geck, Josephine M Boyer, yEvo Students, Margaux Walson, Christopher R L Large, Angela Shang-Mei Hickey, Paul A Rowley and 1 more

Open access · goldAbstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. bioRxiv : the preprint server for biology · 2024
    Article
  6. Experimental evolution ofbioRxiv : the preprint server for biology · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Matthew Bryce TaylorDepartment of Genome Sciences, University of Washington, Seattle, WA 98195, USA.ORCID 0000-0002-8088-6467
Ryan SkophammerWestridge School, Pasadena, CA 91105, USA.ORCID 0000-0002-0229-5864
Alexa R WarwickDepartment of Fisheries and Wildlife, Michigan State University, East Lansing, MI 48824, USA.ORCID 0000-0002-4701-1079
Renee C GeckDepartment of Genome Sciences, University of Washington, Seattle, WA 98195, USA.ORCID 0000-0001-7812-7675
Josephine M BoyerDepartment of Biological Sciences, University of Idaho, Moscow, ID 83844, USA.ORCID 0000-0002-5203-2122
yEvo Students
Margaux WalsonDepartment of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
Christopher R L LargeDepartment of Genome Sciences, University of Washington, Seattle, WA 98195, USA.ORCID 0000-0002-5732-970X
Angela Shang-Mei HickeyDepartment of Genome Sciences, University of Washington, Seattle, WA 98195, USA.ORCID 0000-0003-4407-6894
Paul A RowleyDepartment of Biological Sciences, University of Idaho, Moscow, ID 83844, USA.ORCID 0000-0002-3590-5139
Maitreya J DunhamDepartment of Genome Sciences, University of Washington, Seattle, WA 98195, USA.ORCID 0000-0001-9944-2666
University of Washington · USUniversity of Idaho · USLoras College · USMichigan State University · US

Funding

INTERDISCIPLINARY TRAINING IN GENOMIC SCIENCEST32HG000035 · NHGRI · UNIVERSITY OF WASHINGTON · PI Bruce Colston Trapnell · 1995 to 2026
$24.2M
Functional interpretation of human G6PD variants using multiplexed analyses in S. cerevisiaeF32GM143852 · NIGMS · UNIVERSITY OF WASHINGTON · PI GECK, RENEE CATHERINE · 2021 to 2022
$134k
NHGRI NIH HHS T32 HG000035NIGMS NIH HHS F32 GM143852
6 · The paper itself

Abstract

Antifungal resistance in pathogenic fungi is a growing global health concern. Nonpathogenic laboratory strains of Saccharomyces cerevisiae are an important model for studying mechanisms of antifungal resistance that are relevant to understanding the same processes in pathogenic fungi. We have developed a series of laboratory modules in which high school students used experimental evolution to study antifungal resistance by isolating azole-resistant S. cerevisiae mutants and examining the genetic basis of resistance. We have sequenced 99 clones from these experiments and found that all possessed mutations previously shown to impact azole resistance, validating our approach. We additionally found recurrent mutations in an mRNA degradation pathway and an uncharacterized mitochondrial protein (Csf1) that have possible mechanistic connections to azole resistance. The scale of replication in this initiative allowed us to identify candidate epistatic interactions, as evidenced by pairs of mutations that occur in the same clone more frequently than expected by chance (positive epistasis) or less frequently (negative epistasis). We validated one of these pairs, a negative epistatic interaction between gain-of-function mutations in the multidrug resistance transcription factors Pdr1 and Pdr3. This high school-university collaboration can serve as a model for involving members of the broader public in the scientific process to make meaningful discoveries in biomedical research.

Indexed as

ClotrimazoleDrug Resistance, FungalSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsAntifungal AgentsDNA-Binding ProteinsMutationTranscription FactorsAntifungal AgentsClotrimazoleDNA-Binding ProteinsSaccharomyces cerevisiae ProteinsTranscription Factorsazole resistancecourse-based research experienceexperimental evolutiongenome sequencingscience educationyeast

Identifiers

PMID36173330
PMCPMC9635649
OpenAlexW4297965217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.